CAXTON CORP – Eiger BioPharmaceuticals, Inc. Transaction History
CAXTON CORP portfolio value:
$880,000
portfolio value
CAXTON CORP quarter portfolio value change:
+19.52%
quarter
Eiger BioPharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 144K | $7.53 | 116.88K | |
| Q2 2022 | share | 0.00% | 0 shares | -234K | $6.3 | 116.88K | |
| Q1 2022 | share | 0.00% | 0 shares | 363K | $8.3 | 116.88K | |
| Q4 2021 | share | Decrease | -16.88% | -23.73K shares | -332K | $5.21 | 116.88K |
| Q3 2021 | share | Increase | +1.44% | 1.99K shares | -242K | $6.68 | 140.62K |
| Q2 2021 | share | Increase | +47.34% | 44.54K shares | 348K | $8.52 | 138.62K |
| Q1 2021 | share | Increase | +19.02% | 15.03K shares | -139K | $8.85 | 94.08K |
| Q4 2020 | share | Decrease | -29.97% | -33.82K shares | 53K | $12.29 | 79.04K |
| Q3 2020 | share | Increase | +37.68% | 30.88K shares | 132K | $8.14 | 112.87K |
| Q2 2020 | share | Increase | +0.45% | 366 shares | 232K | $9.6 | 81.98K |
| Q1 2020 | share | Increase | +31.44% | 19.52K shares | -370K | $6.8 | 81.61K |
| Q4 2019 | share | Increase | +0.13% | 81 shares | 289K | $14.9 | 62.09K |
| Q3 2019 | share | Increase | +0.23% | 140 shares | -20K | $10.25 | 62.01K |
| Q2 2019 | share | Increase | +25.55% | 12.59K shares | -33K | $10.6 | 61.87K |
| Q1 2019 | share | Increase | +12.76% | 5.57K shares | 245K | $13.98 | 49.28K |
| Q4 2018 | share | Increase | +71.45% | 18.21K shares | 138K | $10.16 | 43.70K |
| Q3 2018 | share | Increase | 0.00% | 25.49K shares | 306K | $12 | 25.49K |